Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aethlon Medical Inc AEMD

Technology Scientific & Technical Instruments
Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based... see more

Recent & Breaking News (NDAQ:AEMD)

Aethlon Medical's CEO Jim Joyce Interviewed by The Life Sciences Report

Marketwired December 23, 2015

Equity Market Movement at a Glance - Research on Aethlon Medical, Famous Dave's of America, ID Systems and AgroFresh Solutions

ACCESS Newswire December 4, 2015

Aethlon Medical to Participate in the IN3 Medical Device 360 Summit

PR Newswire November 10, 2015

SeeThruEquity's Ajay Tandon and Jay Albany Interviewed by The Life Sciences Report

Marketwired October 29, 2015

Aethlon Medical's James Joyce Interviewed by The Life Sciences Report

Marketwired October 29, 2015

Aethlon Medical To Host Second Quarter Fiscal 2016 Investor Call on November 16, 2015

PR Newswire October 26, 2015

Aethlon Medical Extends Contract with the Defense Advanced Research Projects Agency

PR Newswire September 28, 2015

Aethlon Medical to Present at the Rodman & Renshaw 17th Annual Global Investment Conference

PR Newswire September 2, 2015

Aethlon Medical Announces Fiscal 2016 First Quarter Results

PR Newswire August 13, 2015

Aethlon Medical (AEMD) CEO Note: Nasdaq listing, equity financing and therapeutic pipeline expansion

PR Newswire August 6, 2015

Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015

PR Newswire August 3, 2015

Aethlon Medical, Inc. (Nasdaq: AEMD) to Ring The Nasdaq Stock Market Closing Bell

GlobeNewswire July 23, 2015

Aethlon Medical to Ring the Nasdaq Stock Market Closing Bell on July 24th

PR Newswire July 21, 2015

Aethlon Medical Begins Trading on the Nasdaq Capital Market

PR Newswire July 13, 2015

SeeThruEquity Issues Update Note on Aethlon Medical, Inc. (NASDAQ: AEMD)

ACCESS Newswire July 13, 2015

SeeThruEquity Issues Update Note on Aethlon Medical, Inc. (NASDAQ: AEMD)

ACCESS Newswire July 13, 2015

Aethlon Medical Announces Nasdaq Capital Market Listing Approval

PR Newswire July 8, 2015

Aethlon Medical Announces $6 Million Equity Investment

PR Newswire June 24, 2015

Aethlon Medical Discloses Upcoming Presentations

PR Newswire June 11, 2015

Aethlon Medical Announces Resignation of Inside Director to Comply with NASDAQ Corporate Governance Requirements

PR Newswire June 9, 2015